We here analyzed the expression of SAMHD1 in MCL and whether it correlated to known negative prognostic factors and outcome after cytarabine treatment and high dose chemotherapy in the context of ASCT. The gene discussed is SAMHD1; the disease is mantle cell lymphoma.